This company seems to have been delisted
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Athersys
ATHX
HK$0.11
Share price
-33.50%
Change (1 day)
-98.90%
Change (1 year)
Categories
Athersys (ATHX) - Net assets
Net assets on the balance sheet as of September 2023 : -HK$0.29 Billion
According to Athersys's latest financial reports the company has -HK$0.29 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Athersys - Net assets on balance sheet (from 2005 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $-HK$0.19 Billion | -246% |
| 2021-12-31 | $HK$0.12 B | -47.5% |
| 2020-12-31 | $HK$0.24 B | 34.15% |
| 2019-12-31 | $HK$0.18 B | -46.32% |
| 2018-12-31 | $HK$0.33 B | 84.87% |
| 2017-12-31 | $HK$0.18 B | 110.64% |
| 2016-12-31 | $HK$86.7 M | -43.28% |
| 2015-12-31 | $HK$0.15 B | -5.67% |
| 2014-12-31 | $HK$0.16 B | 5.45% |
| 2013-12-31 | $HK$0.15 B | -2.06% |
| 2012-12-31 | $HK$0.15 B | 176.87% |
| 2011-12-31 | $HK$56.68 M | -19.12% |
| 2010-12-31 | $HK$70.07 M | -52.32% |
| 2009-12-31 | $HK$0.14 B | -39.74% |
| 2008-12-31 | $HK$0.24 B | -34.33% |
| 2007-12-31 | $HK$0.37 B | -9344605.2% |
| 2006-12-31 | $-HK$0.01 Million | -151.26% |
| 2005-12-31 | $HK$0 M | -0.23% |
| 2004-12-31 | $HK$0 M | -99.99% |
| 2003-12-31 | $HK$0.11 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | HK$48.72 B | -17,154.54% | 🇺🇸 USA |
 Pfizer PFE | HK$711.43 B | -249,136.96% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | HK$136.95 B | -48,040.65% | 🇺🇸 USA |
 Moderna
MRNA | HK$79.01 B | -27,757.65% | 🇺🇸 USA |
 Johnson & Johnson JNJ | HK$613.10 B | -214,714.64% | 🇺🇸 USA |
 United States Lime & Minerals USLM | HK$4.17 B | -1,562.31% | 🇺🇸 USA |
 Merck MRK | HK$379.90 B | -133,085.30% | 🇺🇸 USA |
 Sanofi SNY | HK$631.96 B | -221,317.20% | 🇫🇷 France |